Zealand Pharma A/S

Stocks

Real-time Estimate Cboe Europe Other stock markets 04:44:56 2026-06-09 am EDT			5-day change	1st Jan Change
275.35 ^DKK	+9.14%		-10.73%	-41.68%

03:47am	U.S. Futures Rise, European Stocks Mixed	DJ
Jun. 08	Major European indices flat - Zealand Pharma plunges	FW

Published on 05/07/2026 at 02:51 pm EDT - Modified on 05/22/2026 at 08:58 am EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good day, and thank you for standing by. Welcome to the Zealand Pharma Results for Q1 2026 Conference Call. [Operator Instructions] Please be advised

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

03:47am	U.S. Futures Rise, European Stocks Mixed	DJ
Jun. 08	Major European indices flat - Zealand Pharma plunges	FW
Jun. 08	Markets Ask AI for Receipts
Jun. 08	Zealand Pharma plunges following side effects in obesity drug trial	FW
Jun. 08	U.S. Futures Mixed, European Stocks Fall	DJ
Jun. 08	Zealand Pharma shares drop 25% after a quarter of patients quit obesity drug trial	RE
Jun. 08	Chips take a pounding
Jun. 08	Zealand Pharma partner reports robust Phase 3 obesity data	FW
Jun. 07	Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat	RE
Jun. 05	Zealand touts promising tolerability data for obesity drug in mid-stage study	RE
Jun. 05	Zealand Pharma A/S Presents Additional Data From Phase 2 ZUPREME-1 Trial Evaluating Petrelintide At The American Diabetes Association 2026 Scientific Sessions	CI
Jun. 03	Deutsche Bank raises Zealand Pharma price target to DKK 300 (275), reiterates Hold	FW
Jun. 01	BNP Paribas raises Zealand Pharma price target to DKK 350 (275), reiterates Neutral - BN	FW
May. 26	Zealand Pharma A/S Elects Camilla Sylvest to the Board of Directors	CI
May. 15	U.S. Futures Down, European Stocks Fall	DJ